We’d love to hear your feedback on this activity. It helps us to continually improve our products.
Vita-Salute San Raffaele University, Milan, Italy
Professor Massimo Filippi is also Chair of the Neurology and Neurorehabilitation Units, Director of the MS Center, Director of the Neurophysiology Service, and Director of the Neuroimaging Research Unit at IRCCS Scientific Institute San Raffaele, Milan.
Professor Filippi’s research activity has always focused on the definition of the mechanisms leading to progressive accumulation of irreversible physical disability and cognitive impairment in various neurological conditions. He is a member of several national and international scientific societies and boards where he covered or is covering institutional roles. He is the author of over 1460 papers, Editor-in-Chief of the Journal of Neurology, Associate Editor of Human Brain Mapping, Radiology, and Neurological Sciences, and member of the editorial boards of many international scientific journals. He is very often requested as speaker and/or chairman in national and international neurological congresses.
In 2001, Professor Filippi was awarded the Rita Levi Montalcini Prize for his outstanding contributions to the study of MS. According to the study published in Front Neurol 2022;13:845539, he is the 1st of the top 10 most influential authors in MS research (1945-2021) with 39,896 total citations and 522 publications.
Disclosures: Editor-in-Chief of the Journal of Neurology, Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; received compensation for consulting services from Alexion, Almirall, Biogen, Merck Serano, Novartis, Roche, and Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck Serano, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and Teva; participation in Advisory Boards for Alexion, Biogen, Bristol Myers Squibb, Merck, Novartis, Roche, Sanofi, and Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol Myers Squibb, Lilly, Novartis, and Sanofi; and he receives research support from Biogen Idec, Merck Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione ltaliana Sclerosi Multipla.
University Hospital of Münster, Münster, Germany
Professor Heinz Wiendl has been the head of the Department of Neurology at the University Hospital of Münster since 2013. His research focuses on inflammatory neurodegeneration, immune regulation, and protection, as well as monitoring MS and its therapy. His achievements have been recognized with 2 Sobek Prizes from the German Society for MS (DMSG) (2004; 2015).
In 2017, Professor Wiendl was appointed Honorary Professor at Sydney Medical School. Since 2021, he has been a visiting professor at Mashhad University of Medical Sciences. He is the founder and principal investigator of the Body and Brain Institute Münster, a prestigious research building funded by the German Federal Ministry.
Disclosures: Receives honoraria for acting as a member of Scientific Advisory Boards from AbbVie, Alexion, argenx, Bristol Myers Squibb/Celgene, Janssen, Merck, and Novartis; receives speaker honoraria and travel support from Alexion, argenx, Biogen, Bristol Myers Squibb, F. Hoffmann-La Roche Ltd., Sanofi, Merck, Neurodiem, Novartis, Roche, Teva, and WebMD Global; is a paid consultant for AbbVie, Actelion, argenx, Biogen, Bristol Myers Squibb, EMO Serano, Fondazione Cariplo, Gossamer Bio, ldorsia, lmmunic, lmmunovant, Janssen, Lundbeck, Merck, NexGen, Novartis, PSI CRO, Roche, Sanofi, Swiss Multiple Sclerosis Society, UCB, and Worldwide Clinical Trials; and his research is funded by Alexion, Amicus Therapeutics, argenx, Biogen, CSL Behring, Deutsche Forschungsgesellschaft (DFG), Deutsche Myasthenie Gesellschaft e.V., F. Hoffmann-La Roche Ltd., the German Ministry for Education and Research (BMBF), Merck KgaA, Novartis, Roche, and UCB.
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Or use a
.Explore the latest in medical education and stay current in your field. Create a free account to track your learning.